Discovering PATE2: A Potential Drug Target for Various Diseases
![Review Report on PATE2 Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on PATE2 Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
Discovering PATE2: A Potential Drug Target for Various Diseases
PATE2 (PATE-like protein M) is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. PATE2 is a member of the PATE family, which includes proteins that are involved in various cellular processes, including cell signaling, DNA replication, and stress response. The discovery and characterization of PATE2 as a potential drug target or biomarker has significant implications for the development of new therapeutic strategies for a variety of diseases.
Structure and Function
PATE2 is a 21-kDa protein that is expressed in various tissues and cells, including brain, heart, liver, and cancer cells. It has a molecular weight of 42 kDa and a calculated pI of 6.5. PATE2 is a monomer and has four known isoforms, which are different in their size and composition.
The PATE2 protein is characterized by a characteristic domain that includes a catalytic catalytic active site, a 尾-sheet, and a carboxylic acid residue. The catalytic catalytic active site is located at the center of the protein and is responsible for the protein's catalytic activity. The 尾-sheet is a region of the protein that is involved in the formation of hydrogen bonds and provides stability to the protein. The carboxylic acid residue is located at the C-terminus of the protein and is responsible for its acidity and structural stability.
PATE2 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress response. For example, PATE2 has been shown to be involved in the regulation of cell cycle progression and in the DNA replication process. Additionally, PATE2 has been shown to play a role in the stress response, as it has been shown to be involved in the expression of stress genes in response to various stressors, including stress caused by exercise or exposure to environmental toxins.
PATE2 as a Potential Drug Target
The discovery of PATE2 as a potential drug target or biomarker has significant implications for the development of new therapeutic strategies for a variety of diseases. PATE2 has been shown to be involved in the regulation of various cellular processes, including cell signaling, DNA replication, and stress response. As such, it is a potential target for drugs that are designed to modulate these processes and/or disrupt them.
For example, PATE2 has been shown to play a role in the regulation of cell cycle progression, which is a critical process that is involved in the development and progression of cancer. As such, drugs that are designed to inhibit cell cycle progression, such as taxanes or inhibitors of the nuclear export machine, may be effective in treating various types of cancer.
PATE2 has also been shown to be involved in the regulation of DNA replication, which is a critical process that is involved in the development and progression of neurodegenerative diseases. As such, drugs that are designed to disrupt DNA replication, such as inhibitors of the DNA replication complex, may be effective in treating various types of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
In addition to its role in cell signaling and DNA replication, PATE2 has also been shown to play a role in the regulation of stress response. As such, drugs that are designed to disrupt the stress response may be effective in treating various types of stress- related disorders, including anxiety and neuropsychiatric disorders.
Conclusion
PATE2 is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its catalytic catalytic active site, 尾-sheet, and carboxylic acid residue make it a promising target for drugs that are designed to modulate
Protein Name: Prostate And Testis Expressed 2
The "PATE2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PATE2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
PATE3 | PATE4 | PATJ | PATL1 | PATL2 | PATZ1 | PAUPAR | PAWR | PAX1 | PAX2 | PAX3 | PAX4 | PAX5 | PAX6 | PAX6-AS1 | PAX7 | PAX8 | PAX8-AS1 | PAX9 | PAXBP1 | PAXBP1-AS1 | PAXIP1 | PAXIP1-AS2 | PAXIP1-DT | PAXX | PBDC1 | PBK | PBLD | PBOV1 | PBRM1 | PBX1 | PBX2 | PBX3 | PBX3-DT | PBX4 | PBXIP1 | PC | PCA3 | PCAF complex | PCARE | PCAT1 | PCAT14 | PCAT18 | PCAT19 | PCAT2 | PCAT29 | PCAT4 | PCAT5 | PCAT6 | PCAT7 | PCBD1 | PCBD2 | PCBP1 | PCBP1-AS1 | PCBP2 | PCBP2-OT1 | PCBP2P2 | PCBP3 | PCBP3-AS1 | PCBP4 | PCCA | PCCA-DT | PCCB | PCDH1 | PCDH10 | PCDH11X | PCDH11Y | PCDH12 | PCDH15 | PCDH17 | PCDH18 | PCDH19 | PCDH20 | PCDH7 | PCDH8 | PCDH9 | PCDH9-AS3 | PCDH9-AS4 | PCDHA1 | PCDHA10 | PCDHA11 | PCDHA12 | PCDHA13 | PCDHA14 | PCDHA2 | PCDHA3 | PCDHA4 | PCDHA5 | PCDHA6 | PCDHA7 | PCDHA8 | PCDHA9 | PCDHAC1 | PCDHAC2 | PCDHB1 | PCDHB10 | PCDHB11 | PCDHB12 | PCDHB13 | PCDHB14